Ligand Pharmaceuticals Inc (LGND)
110.14
+0.10
(+0.09%)
USD |
NASDAQ |
Nov 04, 13:16
Ligand Pharmaceuticals Market Cap: 2.012B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.010B |
| October 31, 2024 | 1.931B |
| October 30, 2024 | 2.006B |
| October 29, 2024 | 2.111B |
| October 28, 2024 | 2.071B |
| October 25, 2024 | 2.043B |
| October 24, 2024 | 2.028B |
| October 23, 2024 | 1.953B |
| October 22, 2024 | 1.946B |
| October 21, 2024 | 1.951B |
| October 18, 2024 | 1.944B |
| October 17, 2024 | 1.935B |
| October 16, 2024 | 1.958B |
| October 15, 2024 | 1.907B |
| October 14, 2024 | 1.890B |
| October 11, 2024 | 1.881B |
| October 10, 2024 | 1.833B |
| October 09, 2024 | 1.886B |
| October 08, 2024 | 1.881B |
| October 07, 2024 | 1.875B |
| October 04, 2024 | 1.914B |
| October 03, 2024 | 1.868B |
| October 02, 2024 | 1.826B |
| October 01, 2024 | 1.852B |
| September 30, 2024 | 1.829B |
| Date | Value |
|---|---|
| September 27, 2024 | 1.779B |
| September 26, 2024 | 1.816B |
| September 25, 2024 | 1.805B |
| September 24, 2024 | 1.818B |
| September 23, 2024 | 1.821B |
| September 20, 2024 | 1.878B |
| September 19, 2024 | 1.918B |
| September 18, 2024 | 1.894B |
| September 17, 2024 | 1.905B |
| September 16, 2024 | 1.918B |
| September 13, 2024 | 1.914B |
| September 12, 2024 | 1.865B |
| September 11, 2024 | 1.883B |
| September 10, 2024 | 1.868B |
| September 09, 2024 | 1.878B |
| September 06, 2024 | 1.848B |
| September 05, 2024 | 1.884B |
| September 04, 2024 | 1.874B |
| September 03, 2024 | 1.844B |
| August 30, 2024 | 1.933B |
| August 29, 2024 | 1.934B |
| August 28, 2024 | 1.946B |
| August 27, 2024 | 1.943B |
| August 26, 2024 | 1.922B |
| August 23, 2024 | 1.897B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
674.93M
Minimum
Mar 16 2020
2.239B
Maximum
Feb 09 2021
1.260B
Average
1.219B
Median
Dec 04 2019
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 92.19B |
| Agios Pharmaceuticals Inc | 2.546B |
| ADMA Biologics Inc | 4.496B |
| Pieris Pharmaceuticals Inc | 22.71M |
| AnaptysBio Inc | 548.99M |
Market Cap Related Metrics
| PE Ratio | 47.68 |
| PS Ratio | 14.69 |
| PEG Ratio | 0.7892 |
| Price to Book Value | 2.596 |
| Price | 110.14 |
| Earnings Yield | 2.10% |
| PEGY Ratio | 0.7892 |
| Operating PE Ratio | 245.76 |